Stay updated on Safety of Risankizumab in Psoriasis: New Formulation Clinical Trial

Sign up to get notified when there's something new on the Safety of Risankizumab in Psoriasis: New Formulation Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety of Risankizumab in Psoriasis: New Formulation Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Revision: v3.5.3 has been added, replacing Revision: v3.5.2. This indicates a new version of the document, usually due to minor updates or corrections.
    Difference
    0.0%
    Check dated 2026-04-30T05:39:02.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    Added revision: v3.5.2 and removed revision: v3.5.0. This is a minor site-version update that does not affect the study details.
    Difference
    0.0%
    Check dated 2026-04-16T02:03:08.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Revision updated to v3.5.0, replacing the previous v3.4.3 reference.
    Difference
    0.0%
    Check dated 2026-03-25T07:17:59.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3, indicating a minor version update to the page.
    Difference
    0.0%
    Check dated 2026-03-10T15:57:35.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    Revision tag updated to v3.4.2 in the Study Documents section; the rest of the page content and study information remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-17T04:16:56.000Z thumbnail image
  9. Check
    97 days ago
    Change Detected
    Summary
    A new site revision tag, Revision: v3.4.1, appears, with the previous tag Revision: v3.4.0 removed, and a government funding status notice is displayed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-10T01:16:09.000Z thumbnail image

Stay in the know with updates to Safety of Risankizumab in Psoriasis: New Formulation Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety of Risankizumab in Psoriasis: New Formulation Clinical Trial page.